// App-Quantinova.ai

THU0274 : COMBINATION OF MYCOPHENOLATE MOFETIL AND TACROLIMUS FOR REFRACTORY LUPUS NEPHRITIS: A 12-MONTH OPEN-LABELED TRIAL

Researchers

Presenter

  • C. C. Mok

Principal Investigators

  • P. T. Chan

  • L. Y. Ho

  • C. H. To

Medical Centers

  • Medicine, Tuen Mun Hospital, HK, Hong Kong

Locations

  • Hong Kong

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Diabetes

  • Lupus nephritis

  • Shingles

  • Albuminuria

  • Nephritis

  • Lupus

Biomarkers

  • Complement 3

  • Cytochrome C

  • Human albumin

  • Red Blood Cells

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Hydroxychloroquine

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Mycophenolic acid

  • cyclosporin A

  • cyclosporin

  • Oraprine

  • Prednisolone

  • Angiotensin II

  • Tacrolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved